Suppr超能文献

复发胶质母细胞瘤切除术范围对总生存期的影响:临床文章。

Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

机构信息

Department of Neurological Surgery, University of California, San Francisco, California 94143-0112, USA.

出版信息

J Neurosurg. 2012 Dec;117(6):1032-8. doi: 10.3171/2012.9.JNS12504. Epub 2012 Oct 5.

Abstract

OBJECT

Extent of resection (EOR) has been shown to be an important prognostic factor for survival in patients undergoing initial resection of glioblastoma (GBM), but the significance of EOR at repeat craniotomy for recurrence remains unclear. In this study the authors investigate the impact of EOR at initial and repeat resection of GBM on overall survival.

METHODS

Medical records were reviewed for all patients undergoing craniotomy for GBM at the University of California San Francisco Medical Center from January 1, 2005, through August 15, 2009. Patients who had a second craniotomy for pathologically confirmed recurrence following radiation and chemotherapy were evaluated. Volumetric EOR was measured and classified as gross-total resection (GTR, > 95% by volume) or subtotal resection (STR, ≤ 95% by volume) after independent radiological review. Overall survival was compared between groups using univariate and multivariate analysis accounting for known prognostic factors, including age, eloquent location, Karnofsky Performance Status (KPS), and adjuvant therapies.

RESULTS

Multiple resections were performed in 107 patients. Fifty-two patients had initial GTR, of whom 31 (60%) had GTR at recurrence, with a median survival of 20.4 months (standard error [SE] 1.0 months), and 21 (40%) had STR at recurrence, with a median survival of 18.4 months (SE 0.5 months) (difference not statistically significant). Initial STR was performed in 55 patients, of whom 26 (47%) had GTR at recurrence, with a median survival of 19.0 months (SE 1.2 months), and 29 (53%) had STR, with a median survival of 15.9 months (SE 1.2 months) (p = 0.004). A Cox proportional hazards model was constructed demonstrating that age (HR 1.03, p = 0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at repeat resection (HR 0.62, p = 0.02) were independent predictors of survival. Extent of initial resection was not a statistically significant factor (p = 0.13) when repeat EOR was included in the model, suggesting that GTR at second craniotomy could overcome the effect of an initial STR.

CONCLUSIONS

Extent of resection at recurrence is an important predictor of overall survival. If GTR is achieved at recurrence, overall survival is maximized regardless of initial EOR, suggesting that patients with initial STR may benefit from surgery with a GTR at recurrence.

摘要

目的

在接受初始手术切除胶质母细胞瘤(GBM)的患者中,切除范围(EOR)已被证明是生存的重要预后因素,但在复发性疾病的重复开颅手术中 EOR 的意义仍不清楚。在这项研究中,作者研究了初始和重复切除 GBM 时 EOR 对总生存期的影响。

方法

对 2005 年 1 月 1 日至 2009 年 8 月 15 日期间在加利福尼亚大学旧金山医疗中心接受开颅手术治疗 GBM 的所有患者的病历进行了回顾。评估了接受病理证实放疗和化疗后复发的第二次开颅手术的患者。在独立的放射学审查后,将体积 EOR 测量并分类为大体全切除(GTR,体积> 95%)或次全切除(STR,体积≤95%)。使用单变量和多变量分析比较组间的总生存期,该分析考虑了已知的预后因素,包括年龄、语言区、卡诺夫斯基表现状态(KPS)和辅助治疗。

结果

107 例患者进行了多次切除。52 例患者首次行 GTR,其中 31 例(60%)在复发时行 GTR,中位生存期为 20.4 个月(标准误差 [SE] 1.0 个月),21 例(40%)在复发时行 STR,中位生存期为 18.4 个月(SE 0.5 个月)(差异无统计学意义)。55 例患者首次行 STR,其中 26 例(47%)在复发时行 GTR,中位生存期为 19.0 个月(SE 1.2 个月),29 例(53%)行 STR,中位生存期为 15.9 个月(SE 1.2 个月)(p = 0.004)。构建 Cox 比例风险模型表明,年龄(HR 1.03,p = 0.004)、复发时的 KPS 评分(HR 2.4,p = 0.02)和重复切除的 EOR(HR 0.62,p = 0.02)是生存的独立预测因素。当将重复 EOR 纳入模型时,初始切除范围不是统计学上的显著因素(p = 0.13),这表明在第二次开颅手术时达到 GTR 可以克服初始 STR 的影响。

结论

复发时的切除范围是总生存期的重要预测指标。如果在复发时达到 GTR,则最大限度地提高了总生存期,无论初始 EOR 如何,这表明初始 STR 的患者可能受益于在复发时进行 GTR 的手术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验